You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

PAMIDRONATE DISODIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for pamidronate disodium and what is the scope of freedom to operate?

Pamidronate disodium is the generic ingredient in two branded drugs marketed by Novartis, Aesgen, Am Regent, Areva Pharms, Dr Reddys, Fresenius Kabi Usa, Hikma, Hospira, Mn Pharms, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharma Global, and Teva Pharms Usa, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for PAMIDRONATE DISODIUM
Recent Clinical Trials for PAMIDRONATE DISODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Peking Union Medical College HospitalPhase 1
The Hospital for Sick ChildrenN/A
National Cancer Institute (NCI)Phase 1

See all PAMIDRONATE DISODIUM clinical trials

Pharmacology for PAMIDRONATE DISODIUM
Drug ClassBisphosphonate

US Patents and Regulatory Information for PAMIDRONATE DISODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms Inc PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 078373-002 Dec 23, 2008 AP1 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mn Pharms PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 078300-002 Mar 10, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Labs Ltd PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 078520-002 Oct 31, 2008 AP2 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 075290-003 Apr 30, 2001 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PAMIDRONATE DISODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ⤷  Try a Trial ⤷  Try a Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.